Lung Microbiota Signature and Corticosteroid Responses in Pneumonia-Associated Acute Respiratory Distress Syndrome in Hematological Patients

References

• Cuthbertson BH, Rajalingam Y, Harrison S, McKirdy F. The outcome of haematological malignancy in Scottish intensive care units. J Intens Care Soc. 2008;9(2):135–140. doi:10.1177/175114370800900208
   Google Scholar
• Ferreyro BL, Scales DC, Wunsch H, et al. Critical illness in patients with hematologic malignancy: a population-based cohort study. Intensive Care Med. 2021;47(10):1104–1114. doi:10.1007/s00134-021-06502-2
   PubMed Web of Science ®Google Scholar
• Pulte D, Jansen L, Castro FA, Brenner H. Changes in the survival of older patients with hematologic malignancies in the early 21st century. Cancer. 2016;122(13):2031–2040. doi:10.1002/cncr.30003
   PubMed Web of Science ®Google Scholar
• Hu Y, Shen J, An Y, Liu S. Early high dose corticosteroid therapy in hematopoietic stem cell transplantation patients with acute respiratory distress syndrome: a propensity score matched study. Ther Adv Respir Dis. 2021;15:17534666211009397. doi:10.1177/17534666211009397
   Web of Science ®Google Scholar
• Schmidt M, Schellongowski P, Patroniti N, et al. Six-month outcome of immunocompromised patients with severe acute respiratory distress syndrome rescued by extracorporeal membrane oxygenation. an international multicenter retrospective study. Am J Respir Crit Care Med. 2018;197(10):1297–1307. doi:10.1164/rccm.201708-1761OC
   PubMed Web of Science ®Google Scholar
• Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671–1684. doi:10.1056/NEJMoa051693
   PubMed Web of Science ®Google Scholar
• Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. 2007;131(4):954–963. doi:10.1378/chest.06-2100
   PubMed Web of Science ®Google Scholar
• Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): society of critical care medicine (SCCM) and European society of intensive care medicine (ESICM) 2017. Crit Care Med. 2017;45(12):2078–2088. doi:10.1097/CCM.0000000000002737
   PubMed Web of Science ®Google Scholar
• Villar J, Ferrando C, Martinez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267–276. doi:10.1016/S2213-2600(19)30417-5
   PubMed Web of Science ®Google Scholar
• Sinha P, Furfaro D, Cummings MJ, et al. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am J Respir Crit Care Med. 2021;204(11):1274–1285. doi:10.1164/rccm.202105-1302OC
   PubMed Web of Science ®Google Scholar
• Wang H, Zhou Q, Dai W, et al. Lung microbiota and pulmonary inflammatory cytokines expression vary in children with tracheomalacia and adenoviral or mycoplasma pneumoniae pneumonia. Front Pediatr. 2019;7:265. doi:10.3389/fped.2019.00265
   PubMed Web of Science ®Google Scholar
• Shenoy MK, Iwai S, Lin DL, et al. Immune response and mortality risk relate to distinct lung microbiomes in patients with HIV and pneumonia. Am J Respir Crit Care Med. 2017;195(1):104–114. doi:10.1164/rccm.201603-0523OC
   PubMed Web of Science ®Google Scholar
• Mitting RB, Ray S, Raffles M, et al. Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome. PLoS One. 2019;14(11):e0225737. doi:10.1371/journal.pone.0225737
   PubMed Web of Science ®Google Scholar
• Ritter LA, Britton N, Heil EL, et al. The impact of corticosteroids on secondary infection and mortality in critically ill COVID-19 patients. J Intensive Care Med. 2021;36(10):1201–1208. doi:10.1177/08850666211032175
   PubMed Web of Science ®Google Scholar
• Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669
   PubMed Web of Science ®Google Scholar
• Chen H, Yin Y, Gao H, et al. Clinical utility of in-house metagenomic next-generation sequencing for the diagnosis of lower respiratory tract infections and analysis of the host immune response. Clin Infect Dis. 2020;71(Suppl 4):S416–S426. doi:10.1093/cid/ciaa1516
   PubMed Web of Science ®Google Scholar
• Franzosa EA, McIver LJ, Rahnavard G, et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat Methods. 2018;15(11):962–968. doi:10.1038/s41592-018-0176-y
   PubMed Web of Science ®Google Scholar
• Segata N, Waldron L, Ballarini A, Narasimhan V, Jousson O, Huttenhower C. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods. 2012;9(8):811–814. doi:10.1038/nmeth.2066
   PubMed Web of Science ®Google Scholar
• Liu YX, Qin Y, Chen T, et al. A practical guide to amplicon and metagenomic analysis of microbiome data. Protein Cell. 2021;12(5):315–330. doi:10.1007/s13238-020-00724-8
   PubMed Web of Science ®Google Scholar
• Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. doi:10.1186/gb-2011-12-6-r60
   PubMed Web of Science ®Google Scholar
• Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611–620. doi:10.1016/S2213-2600(14)70097-9
   PubMed Web of Science ®Google Scholar
• Tongyoo S, Permpikul C, Mongkolpun W, et al. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care. 2016;20(1):329. doi:10.1186/s13054-016-1511-2
   PubMed Web of Science ®Google Scholar
• Hu Y, Jiang Y, Liu S, Shen J, An Y. Phenotypes, lung microbiota and cytokine responses in pneumonia after hematopoietic stem cell transplantation. J Inflamm Res. 2021;14:6055–6065. doi:10.2147/JIR.S338914
   PubMed Web of Science ®Google Scholar
• Auletta JJ, Lazarus HM. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant. 2005;35(9):835–857. doi:10.1038/sj.bmt.1704966
   PubMed Web of Science ®Google Scholar
• Park BG, Park CJ, Jang S, et al. Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients. Leuk Res. 2015;39(12):1334–1341. doi:10.1016/j.leukres.2015.09.010
   PubMed Web of Science ®Google Scholar
• van Tilburg CM, van Gent R, Bierings MB, et al. Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up. Br J Haematol. 2011;152(2):201–210. doi:10.1111/j.1365-2141.2010.08478.x
   PubMed Web of Science ®Google Scholar
• Voiriot G, Visseaux B, Cohen J, et al. Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care. 2016;20(1):375. doi:10.1186/s13054-016-1517-9
   PubMed Web of Science ®Google Scholar
• Jamieson AM, Yu S, Annicelli CH, Medzhitov R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe. 2010;7(2):103–114. doi:10.1016/j.chom.2010.01.010
   PubMed Web of Science ®Google Scholar
• O’Dwyer DN, Zhou X, Wilke CA, et al. Lung dysbiosis, inflammation, and injury in hematopoietic cell transplantation. Am J Respir Crit Care Med. 2018;198(10):1312–1321. doi:10.1164/rccm.201712-2456OC
   PubMed Web of Science ®Google Scholar